X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3784) 3784
Publication (359) 359
Dissertation (47) 47
Book Chapter (42) 42
Book Review (38) 38
Conference Proceeding (10) 10
Web Resource (4) 4
Book / eBook (3) 3
Government Document (2) 2
Magazine Article (2) 2
Data Set (1) 1
Newspaper Article (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
arsenic trioxide (3579) 3579
humans (2143) 2143
index medicus (1622) 1622
apoptosis (1351) 1351
acute promyelocytic leukemia (1281) 1281
oncology (1169) 1169
arsenic (867) 867
animals (749) 749
cancer (746) 746
apoptosis - drug effects (724) 724
arsenicals - pharmacology (703) 703
hematology (702) 702
oxides - pharmacology (666) 666
cell line, tumor (576) 576
antineoplastic agents - pharmacology (575) 575
leukemia (575) 575
male (538) 538
female (507) 507
leukemia, promyelocytic, acute - drug therapy (497) 497
trans-retinoic acid (494) 494
chemotherapy (478) 478
in-vitro (424) 424
mice (413) 413
antineoplastic agents - therapeutic use (396) 396
pharmacology & pharmacy (385) 385
arsenicals - therapeutic use (384) 384
oxides - therapeutic use (372) 372
biochemistry & molecular biology (359) 359
oxidative stress (349) 349
cell biology (328) 328
therapy (317) 317
expression (314) 314
proteins (314) 314
activation (309) 309
adult (304) 304
acute myeloid-leukemia (285) 285
middle aged (279) 279
retinoic acid (266) 266
analysis (258) 258
toxicology (257) 257
arsenicals - administration & dosage (255) 255
inhibition (253) 253
reactive oxygen species - metabolism (246) 246
oxides - administration & dosage (245) 245
toxicity (244) 244
cell proliferation - drug effects (240) 240
induced apoptosis (238) 238
cells (236) 236
differentiation (232) 232
dose-response relationship, drug (226) 226
research (223) 223
treatment outcome (221) 221
down-regulation (212) 212
antineoplastic combined chemotherapy protocols - therapeutic use (209) 209
aged (204) 204
growth (202) 202
care and treatment (200) 200
flow cytometry (200) 200
cell cycle (199) 199
induction (199) 199
leukemia, promyelocytic, acute - pathology (194) 194
gene expression (189) 189
cell survival - drug effects (186) 186
reactive oxygen species (185) 185
autophagy (183) 183
health aspects (182) 182
arsenicals (180) 180
medicine, research & experimental (179) 179
as2o3 (177) 177
glutathione (176) 176
tumor cells, cultured (176) 176
cytotoxicity (174) 174
article (170) 170
signal transduction (167) 167
signal transduction - drug effects (167) 167
cancer-cells (166) 166
drug synergism (166) 166
death (165) 165
arsenic trioxide as2o3 (163) 163
leukemia, promyelocytic, acute - genetics (161) 161
tumors (161) 161
tretinoin - therapeutic use (158) 158
all-trans retinoic acid (156) 156
oxides - toxicity (156) 156
survival (156) 156
arsenicals - adverse effects (155) 155
medicine & public health (155) 155
mechanisms (151) 151
cell death (150) 150
blotting, western (148) 148
medicine (148) 148
oxides - adverse effects (148) 148
antineoplastic agents - adverse effects (142) 142
mitochondria (139) 139
kinases (138) 138
antineoplastic agents - administration & dosage (135) 135
tretinoin - administration & dosage (134) 134
cancer therapies (131) 131
growth-inhibition (131) 131
gene-expression (130) 130
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3746) 3746
Chinese (82) 82
Japanese (27) 27
German (17) 17
Polish (15) 15
Spanish (15) 15
French (14) 14
Korean (13) 13
Russian (3) 3
Danish (2) 2
Persian (2) 2
Portuguese (2) 2
Czech (1) 1
Dutch (1) 1
Italian (1) 1
Slovenian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1908, University of Toronto studies. Papers from the chemical laboratories, Volume no. 74, [1364]-1372
Book
Investigative Ophthalmology and Visual Science, ISSN 0146-0404, 2015, Volume 56, Issue 11, pp. 6663 - 6670
Journal Article
1907, University of Toronto studies. Papers from the chemical laboratories, Volume no. 65, [292]-305
Book
ACS Nano, ISSN 1936-0851, 03/2015, Volume 9, Issue 3, pp. 2749 - 2759
Delivery of arsenic trioxide (ATO), a clinical anticancer drug, has drawn much attention to improve its pharmacokinetics and bioavailability for efficient... 
cancer therapy | cancer diagnosis | monitoring | arsenic trioxide | imaging | activatable T
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2018, Volume 72, Issue 16, p. C50
Journal Article
Blood, ISSN 0006-4971, 11/2014, Volume 124, Issue 23, pp. 3345 - 3355
The past 40 years have witnessed major advances in defining the cytogenetic aberrations, mutational landscape, epigenetic profiles, and expression changes... 
AML | DIAGNOSIS | STEM-CELLS | POLYMERASE-CHAIN-REACTION | RISK STRATIFICATION | TREATMENT RESPONSE | THERAPEUTIC IMPLICATIONS | PROGNOSTIC RELEVANCE | PREDICTS RELAPSE | HEMATOLOGY | ARSENIC TRIOXIDE
Journal Article
ONCOLOGY RESEARCH AND TREATMENT, ISSN 2296-5270, 2019, Volume 42, Issue 5, pp. 293 - 293
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 03/2015, Volume 33, Issue 9, pp. 1091 - 1091
Journal Article
1997, 2 v.
Dillon Consulting was retained by the Dept. of Indian and Northern Affairs Canada (DIAND) to assess and prepare a report on the current market, technology and... 
Northwest Territories | resource management | Canada | arsenic compounds | arsenic trioxide | economic analysis | Giant Mine | mining | mineral industry
Book
Leukemia Research, ISSN 0145-2126, 01/2019, Volume 76, pp. 11 - 14
In this work, we investigated the stability of arsenic trioxide (ATO) used in leukemia treatment, encapsulated with nanoliposome, with the aid of ultrasound... 
Arsenic species | Liposome | Arsenic trioxide | ONCOLOGY | HEMATOLOGY
Journal Article
Journal of Investigative Medicine, ISSN 1081-5589, 2019
Most of the International Prognostic Scoring System (IPSS) high-risk patients with myelodysplastic syndrome partly responded to hypomethylating therapy even... 
apoptosis | decitabine | myelodysplastic syndrome | arsenic trioxide | endoplasmic reticulum stress
Journal Article
Journal of proteome research, ISSN 1535-3893, 9/2017, Volume 16, Issue 9, pp. 3147 - 3157
Ki-1/57 is a nuclear and cytoplasmic regulatory protein first identified in malignant cells from Hodgkin’s lymphoma. It is involved in gene expression... 
Ki-1 | posttranslational modifications | SUMOylation | arsenic trioxide | PML-NBs | CGI-55
Journal Article
Cancer, ISSN 0008-543X, 01/2020, Volume 126, Issue 2, pp. 256 - 259
Arsenic trioxide (ATO) is highly effective for the treatment of patients with acute promyelocytic leukemia (APL). In their study, Chen et al analyze the... 
cost‐effectiveness | acute promyelocytic leukemia | ATO | arsenic trioxide | APL
Journal Article
Cell death & disease, ISSN 2041-4889, 06/2016, Volume 7, Issue 6, pp. e2253 - e2253
Journal Article
by Xu, XH and Wang, HB and Li, HY and Hu, XQ and Zhang, Y and Guan, XY and Toy, PH and Sun, HZ
CHEMICAL COMMUNICATIONS, ISSN 1359-7345, 11/2019, Volume 55, Issue 87, pp. 13120 - 13123
Histone H3.3 was identified as an arsenic-binding protein of S-dimethylarsino-glutathione (ZIO-101, darinaparsin (R)) in leukemia cells by GE-ICP-MS. Such a... 
INDUCTION | BINDING | CHEMISTRY, MULTIDISCIPLINARY | GROWTH | ACUTE PROMYELOCYTIC LEUKEMIA | ARSENIC TRIOXIDE
Journal Article
Experimental Cell Research, ISSN 0014-4827, 01/2020, Volume 386, Issue 2, p. 111739
Chemo-resistance to conventional therapy is a major barrier requiring further investigation in hepatocellular carcinoma (HCC). Cancer stem like cells (CSCs)... 
Chemo-resistance | Arsenic trioxide | miRNA | Hepatocellular carcinoma | Cancer stem cell-like cells
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.